Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Spire Healthcare Sells Two Cancer Treatment Sites For GBP12 Million

1st Nov 2019 09:21

(Alliance News) - Hospital group Spire Healthcare Group PLC on Friday said it has sold two sites to Genesis Cancer Care UK Ltd for GBP12.0 million as part of a partnership with the private care services provider.

Hampshire-based Genesis has acquired Spire's Baddow Specialist Care Centre in Chelmsford, Essex, and the Bristol Cancer Centre in southwest England. Spire said it will retain a 50% share of chemotherapy gross profits from the Bristol site, however.

Spire said: "The sale of the two sites completes the first step of the new partnership between Spire Healthcare and GenesisCare to create a national end-to-end private cancer care pathway."

Spire shares were 1.6% higher at 118.70 pence each in London on Friday morning.

By Eric Cunha; [email protected]

Copyright 2019 Alliance News Limited. All Rights Reserved.


Related Shares:

Spire Healthcare
FTSE 100 Latest
Value8,820.65
Change33.63